Showing results (4101-4110 of 5,590) with videos related to

Sort By:
Pageof 559
Theranostics|March 9, 2026
CEBPB-high dormant tumor cells drive immune evasion via S100A8 orchestrated tumor-associated macrophages reprogrammingJin Bai, Huilan Su, Shunxi Wang, et al.
Theranostics|March 9, 2026
Biomimetic Cell Membrane-coated Nanovaccines in Anti-tumor ImmunotherapyYizhang Chen, Weiyue Zhang, Xin Huang
Theranostics|March 9, 2026
Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancerManon Teisseire, Arthur Karaulic, Julien Parola, et al.
Theranostics|April 17, 2026
Cell-drug conjugates: a novel drug delivery system for cancer therapyXiaoli Cheng, Mengyuan He, Yuanye Zeng, et al.
Theranostics|April 17, 2026
Translational Models for Glioblastoma: Revolutionizing Drug Development and Personalized Medicine through Clinical InsightsGaeun Lee, Yu Jin Kim, Sharon Jeeho Ham, et al.
Theranostics|April 17, 2026
One-step knock-in CAR constructs in human NK cells enable scalable, TGFβ1-resistant immunotherapy for solid tumorsSu-Min Yee, Ji Hye Jeong, Daeun Kim, et al.
Theranostics|April 17, 2026
Sensitization strategy for sonodynamic therapySinong Li, Ziyi Yang, Ying Zhang, et al.
Theranostics|May 7, 2026
Specific imaging of bacterial infection: a translational approach using positron emission tomography and gallium-68-labeled maltohexaoseSophie M Wegener, Desiree Weiberg, James T Thackeray, et al.
Theranostics|May 7, 2026
A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagySang-Hyo Kim, Yoonbin Park, Hwa-Yeong Jin, et al.
Theranostics|May 7, 2026
Esterase-responsive albumin-binding PROTAC-mediated BRD4 degradation for cancer immunotherapyHoyeon Lee, Sojin Jeong, Juwon Park, et al.
Pageof 559